Dyadic Reports 2021 Year End Results and Recent Company

New research, license and collaboration agreement with Janssen for the development and manufacture of therapeutic proteinsReceived NIIMBL coronavirus grant...

Related Keywords

United States ,South Africa ,Oslo ,Norway ,India ,American ,Mark Emalfarb ,Joseph Hazelton ,Phibro Animal Health ,National Institute For Innovation ,Janssen Biotech Inc ,Dyadic International Inc ,African Health Products Regulatory Authority ,Janssen Pharmaceutical Companies Of Johnson ,Leadership Team ,Human Health ,Animal Health ,Rubic Consortium ,Company Progress ,Foreign Currency Exchange ,University Of Oslo ,White House ,American Rescue ,Chief Business ,Chief Executive Officer ,Collaboration Agreement ,Janssen Biotech ,Janssen Pharmaceutical Companies ,National Institute ,Manufacturing Biopharmaceuticals ,American Rescue Plan ,Epygen Biotech ,Reviewed Journals ,Chief Business Officer ,Currency Exchange ,Non Operating Items ,Toll Free ,Investor Relations ,Nasdaq Dyai ,Dyadic International ,Nc ,